Research Progress of DNA Methylation in Endometrial Cancer

Endometrial cancer (EC)) is one of the most common malignant tumors of the female genital system, with an increasing incidence and mortality, worldwide. Although the therapeutic strategy of EC is still complicated and challenging, further understanding of carcinogenesis from a gene perspective would...

Full description

Bibliographic Details
Main Authors: Ting Xu, Hongmei Ding, Jie Chen, Jiahui Lei, Meng Zhao, Bingyu Ji, Youguo Chen, Songbing Qin, Qinqin Gao
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/7/938
_version_ 1827597785065586688
author Ting Xu
Hongmei Ding
Jie Chen
Jiahui Lei
Meng Zhao
Bingyu Ji
Youguo Chen
Songbing Qin
Qinqin Gao
author_facet Ting Xu
Hongmei Ding
Jie Chen
Jiahui Lei
Meng Zhao
Bingyu Ji
Youguo Chen
Songbing Qin
Qinqin Gao
author_sort Ting Xu
collection DOAJ
description Endometrial cancer (EC)) is one of the most common malignant tumors of the female genital system, with an increasing incidence and mortality, worldwide. Although the therapeutic strategy of EC is still complicated and challenging, further understanding of carcinogenesis from a gene perspective would allow an effort to improve therapeutic precision in this complex malignancy. DNA methylation is the most widely studied epigenetic alteration in human tumors. Aberrant DNA methylation events, resulting in altered gene expression, are features of many tumor types. In this review, we provide an update on evidence about the roles of aberrant DNA methylation within some classical tumor suppressor genes and oncogenes in endometrial carcinogenesis, and report on recent advances in the understanding of the contribution of aberrant DNA methylation to EC, as well as opportunities and challenges of DNA methylation in EC management and prevention.
first_indexed 2024-03-09T03:39:15Z
format Article
id doaj.art-453f909881f14400820991b5575da7d3
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T03:39:15Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-453f909881f14400820991b5575da7d32023-12-03T14:43:29ZengMDPI AGBiomolecules2218-273X2022-07-0112793810.3390/biom12070938Research Progress of DNA Methylation in Endometrial CancerTing Xu0Hongmei Ding1Jie Chen2Jiahui Lei3Meng Zhao4Bingyu Ji5Youguo Chen6Songbing Qin7Qinqin Gao8Institute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaInstitute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaInstitute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaInstitute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaDepartment of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaInstitute for Fetology, The First Affiliated Hospital of Soochow University, Suzhou 215006, ChinaEndometrial cancer (EC)) is one of the most common malignant tumors of the female genital system, with an increasing incidence and mortality, worldwide. Although the therapeutic strategy of EC is still complicated and challenging, further understanding of carcinogenesis from a gene perspective would allow an effort to improve therapeutic precision in this complex malignancy. DNA methylation is the most widely studied epigenetic alteration in human tumors. Aberrant DNA methylation events, resulting in altered gene expression, are features of many tumor types. In this review, we provide an update on evidence about the roles of aberrant DNA methylation within some classical tumor suppressor genes and oncogenes in endometrial carcinogenesis, and report on recent advances in the understanding of the contribution of aberrant DNA methylation to EC, as well as opportunities and challenges of DNA methylation in EC management and prevention.https://www.mdpi.com/2218-273X/12/7/938DNA methylationtumor suppressor genesoncogenesendometrial cancer
spellingShingle Ting Xu
Hongmei Ding
Jie Chen
Jiahui Lei
Meng Zhao
Bingyu Ji
Youguo Chen
Songbing Qin
Qinqin Gao
Research Progress of DNA Methylation in Endometrial Cancer
Biomolecules
DNA methylation
tumor suppressor genes
oncogenes
endometrial cancer
title Research Progress of DNA Methylation in Endometrial Cancer
title_full Research Progress of DNA Methylation in Endometrial Cancer
title_fullStr Research Progress of DNA Methylation in Endometrial Cancer
title_full_unstemmed Research Progress of DNA Methylation in Endometrial Cancer
title_short Research Progress of DNA Methylation in Endometrial Cancer
title_sort research progress of dna methylation in endometrial cancer
topic DNA methylation
tumor suppressor genes
oncogenes
endometrial cancer
url https://www.mdpi.com/2218-273X/12/7/938
work_keys_str_mv AT tingxu researchprogressofdnamethylationinendometrialcancer
AT hongmeiding researchprogressofdnamethylationinendometrialcancer
AT jiechen researchprogressofdnamethylationinendometrialcancer
AT jiahuilei researchprogressofdnamethylationinendometrialcancer
AT mengzhao researchprogressofdnamethylationinendometrialcancer
AT bingyuji researchprogressofdnamethylationinendometrialcancer
AT youguochen researchprogressofdnamethylationinendometrialcancer
AT songbingqin researchprogressofdnamethylationinendometrialcancer
AT qinqingao researchprogressofdnamethylationinendometrialcancer